The meeting covered director elections, auditor ratification, a reverse stock split, executive compensation, and equity plan amendments. All proposals were approved by stockholders, with final results to be filed with the SEC. Stockholders were invited to submit questions.Based on Kairos Pharma, Lt…
The meeting covered director elections, auditor ratification, a reverse stock split, executive compensation, and equity plan amendments. All proposals were approved by stockholders, with final results to be filed with the SEC. Stockholders were invited to submit questions.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
